These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33128287)

  • 1. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.
    Tong H; Gan C; Wei B; Wang ZD; Li XD; Qian SJ; Huan H; Zhang LH; Yang Z; Chen YL; Gu YH; Chen LX; Yang YH; Wu H; Tang CW
    J Dig Dis; 2021 Jan; 22(1):31-40. PubMed ID: 33128287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
    J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
    Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
    Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.
    Zhong BY; Wang WS; Shen J; Du H; Zhang S; Li WC; Yin Y; Yang J; Ni CF; Zhu XL
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1597-1608. PubMed ID: 34240232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients.
    Liao Y; Zhang L; Wang JT; Yue ZD; Fan ZH; Wu YF; Zhang Y; Dong CB; Wang XQ; Cui T; Meng MM; Bao L; Chen SB; Liu FQ; Wang L
    Sci Rep; 2023 Sep; 13(1):15244. PubMed ID: 37709823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of Child-Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.
    Liu J; Zhou C; Wang Y; Yang C; Shi Q; Huang S; Chen Y; Li T; Xiong B
    Abdom Radiol (NY); 2021 Jul; 46(7):3464-3470. PubMed ID: 33660042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
    Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
    Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
    Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.
    Yang Y; Liang X; Yang S; He X; Huang M; Shi W; Luo J; Duan C; Feng X; Fu S; Lu L
    Eur J Radiol; 2022 Sep; 154():110384. PubMed ID: 35667296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Yang C; Liu J; Shi Q; Huang S; Zhou C; Wang Y; Li T; Chen Y; Xiong B
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2893-2902. PubMed ID: 33973270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight/Obesity Increases the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients.
    Gu L; Yin X; Cheng Y; Wang X; Zhang M; Zou X; Wang L; Zhuge Y; Zhang F
    J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
    Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
    Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year.
    Cai W; Lin H; Qi R; Lin X; Zhao Y; Chen W; Huang Z
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):93-101. PubMed ID: 34523022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS.
    Xia Y; Tie J; Wang G; Zhuge Y; Wu H; Xue H; Xu J; Zhang F; Zhao L; Huang G; Zhang M; Wei B; Li P; Wu W; Chen C; Tang C; Zhang C
    Hepatol Int; 2023 Aug; 17(4):967-978. PubMed ID: 36807252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.